Elizabeth Yeu Lin insider trades

Open-market stock purchases and sales by Elizabeth Yeu Lin, Chief Medical Officer at Tarsus Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 21, 2021.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -42%.

Recent trades

DateStockTradeValue
Sep 4, 2026TARS Tarsus Pharmaceuticals, IncSold$458K
Sep 4, 2026TARS Tarsus Pharmaceuticals, IncSold$485K
Sep 4, 2026TARS Tarsus Pharmaceuticals, IncSold$143K
Sep 2, 2026TARS Tarsus Pharmaceuticals, IncSold$431K
Sep 2, 2026TARS Tarsus Pharmaceuticals, IncSold$127K
Sep 1, 2026TARS Tarsus Pharmaceuticals, IncSold$340K
Mar 19, 2026TARS Tarsus Pharmaceuticals, IncSold$26.1K
Mar 18, 2026TARS Tarsus Pharmaceuticals, IncSold$26K
Mar 17, 2026TARS Tarsus Pharmaceuticals, IncSold$26K
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Dec 16, 2025TARS Tarsus Pharmaceuticals, IncSold$165K
Dec 15, 2025TARS Tarsus Pharmaceuticals, IncBought (not open market)—

Companies traded

  • TARS Tarsus Pharmaceuticals, Inc: 3 buys, 11 sales, last Sep 4, 2026
  • STAA Staar Surgical Co: 1 buy, last Jun 18, 2025

Get free alerts when Elizabeth Yeu Lin files a new trade →